Literature DB >> 18927417

Human infections with verocytotoxin-producing Escherichia coli O157--10 years of E. coli O157 serodiagnosis.

Henrik Chart1, Thomas Cheasty1.   

Abstract

From 1997 to 2007, the Laboratory of Enteric Pathogens (LEP), Health Protection Agency, UK, received sera from 2148 patients for testing for antibodies to the LPS of verocytotoxin-producing Escherichia coli (VTEC) O157. A total of 676 (31.5 %) sera had antibodies binding the LPS of E. coli O157 and the majority of patients were below the age of 10 years, a trend observed for both males and females. Antibody-positive patients had haemolytic uraemic syndrome (HUS) in 79.3 % of cases and most of these presented with the atypical (D-) form of HUS. Nine patients were shown to have antibodies to the LPS of E. coli belonging to serogroups O26 (4), O103 (2), O111 (1) and O145 (2) and one patient had antibodies to the somatic antigens of both E. coli O26 and O103. The serodiagnosis of infections with E. coli O157 and other VTEC continues to be an important adjunct to bacteriology. Where clinicians suspect the involvement of a VTEC in disease, patients' sera should be submitted to the LEP for analysis without delay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927417     DOI: 10.1099/jmm.0.2008/003632-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.

Authors:  Luciano J Melli; Andrés E Ciocchini; Ana J Caillava; Nicolás Vozza; Isabel Chinen; Marta Rivas; Mario F Feldman; Juan E Ugalde; Diego J Comerci
Journal:  J Clin Microbiol       Date:  2014-12-03       Impact factor: 5.948

2.  Etiological diagnosis of post-diarrheal hemolytic uremic syndrome (HUS): humoral response contribution.

Authors:  Gabriela A Fiorentino; Elizabeth Miliwebsky; María Victoria Ramos; Gisela Zolezzi; Isabel Chinen; Glenda Guzmán; Rubén Nocera; Romina Fernández-Brando; Adriana Santiago; Ramón Exeni; Marina S Palermo
Journal:  Pediatr Nephrol       Date:  2022-07-08       Impact factor: 3.714

3.  Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Authors:  Deborah J Stearns-Kurosawa; Sun-Young Oh; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh; James Papin; Joel Henderson; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2013-02-10       Impact factor: 4.307

4.  Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience.

Authors:  Emily I Schindler; Patricia Sellenriek; Gregory A Storch; Phillip I Tarr; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2014-07-30       Impact factor: 5.948

5.  Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014-2018.

Authors:  C Sawyer; B Vishram; C Jenkins; F Jorgensen; L Byrne; A F W Mikhail; T J Dallman; K Carroll; L Ahyow; Q Vahora; G Godbole; S Balasegaram
Journal:  Epidemiol Infect       Date:  2021-04-19       Impact factor: 2.451

6.  Large outbreak of verocytotoxin-producing Escherichia coli O157 infection in visitors to a petting farm in South East England, 2009.

Authors:  C Ihekweazu; K Carroll; B Adak; G Smith; G C Pritchard; I A Gillespie; N Q Verlander; L Harvey-Vince; M Reacher; O Edeghere; B Sultan; R Cooper; G Morgan; P T N Kinross; N S Boxall; A Iversen; G Bickler
Journal:  Epidemiol Infect       Date:  2011-11-18       Impact factor: 2.451

7.  Highly virulent Escherichia coli O26, Scotland.

Authors:  Kevin G J Pollock; Sheetal Bhojani; T James Beattie; Lesley Allison; Mary Hanson; Mary E Locking; John M Cowden
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

Review 8.  Management of hemolytic uremic syndrome.

Authors:  David Kavanagh; Shreya Raman; Neil S Sheerin
Journal:  F1000Prime Rep       Date:  2014-12-01

9.  Fecal diagnostics in combination with serology: best test to establish STEC-HUS.

Authors:  Kioa L Wijnsma; Sheila A M van Bommel; Thea van der Velden; Elena Volokhina; Michiel F Schreuder; Lambertus P van den Heuvel; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2016-05-30       Impact factor: 3.714

10.  Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential.

Authors:  Frances Dowen; Katrina Wood; Alison L Brown; Jennifer Palfrey; David Kavanagh; Vicky Brocklebank
Journal:  Clin Kidney J       Date:  2017-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.